Deep Breathe, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Deep Breathe, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Deep Breathe, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 23, 2026 to Oct 23, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code POK appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 45 King St., Suite 300, London, N6A1B8, CA. Recorded on K261679, decision dated Oct 23, 2026.
Device categories in this collection
Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BlineSlideK261679 | Deep Breathe, Inc. | 510(k) clearance | Oct 23, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
